Jose E Velazquez Vega
Overview
Explore the profile of Jose E Velazquez Vega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali N, Eaton B, Fangusaro J, Castellino R, Velazquez Vega J, Chern J, et al.
Neurooncol Pract
. 2025 Feb;
12(1):160-167.
PMID: 39917758
We report a case of a 10-year-old male with a right frontal diffuse pediatric-type high-grade glioma (HGG), H3-wild-type (WT), and IDH-WT, diagnosed at the age of 9 years, who underwent...
2.
Sirotnikov S, Dehner L, Velazquez Vega J, Cheng J
Pediatr Dev Pathol
. 2024 Sep;
28(1):68-73.
PMID: 39340393
Langerhans cell sarcoma (LCS), a rare malignant neoplasm in the general category of myeloid neoplasms characterized by overtly malignant Langerhans cells (LC) with conspicuous mitotic activity including atypical forms. Although...
3.
Chien F, Michaud M, Bakhtiari M, Schroff C, Snuderl M, Velazquez Vega J, et al.
bioRxiv
. 2024 Jul;
PMID: 38979174
The tumor microenvironment (TME) of medulloblastoma (MB) influences progression and therapy response, presenting a promising target for therapeutic advances. Prior single-cell analyses have characterized the cellular components of the TME...
4.
Cleveland A, Malawsky D, Churiwal M, Rodriguez C, Reed F, Schniederjan M, et al.
Acta Neuropathol Commun
. 2023 Jan;
11(1):8.
PMID: 36635771
We show that Polycomb Repressive Complex-2 (PRC2) components EED and EZH2 maintain neural identity in cerebellar granule neuron progenitors (CGNPs) and SHH-driven medulloblastoma, a cancer of CGNPs. Proliferating CGNPs and...
5.
Goodman A, Velazquez Vega J, Glenn C, Olson J
J Neurooncol
. 2022 Jun;
158(2):179-224.
PMID: 35648306
Target Population: These recommendations apply to adult patients with progressive or recurrent glioblastoma (GBM). Question: For adult patients with progressive glioblastoma does testing for Isocitrate Dehydrogenase (IDH) 1 or 2...
6.
Fuller M, Leino D, Reyes-Mugica M, Kovach A, Velazquez Vega J, Caltharp S, et al.
Pediatr Dev Pathol
. 2022 Apr;
25(5):499-503.
PMID: 35400217
Introduction: Appendicular foreign bodies are a rare, under-described cause of appendicitis. We performed this study to determine the varied causes and consequences of foreign-body appendicitis. Methods: On retrospective review of...
7.
Min T, Allen J, Velazquez Vega J, Neill S, Weinberg B
Tomography
. 2021 Jul;
7(2):228-237.
PMID: 34199376
Glioblastoma (GBM) is the most common and deadly primary brain tumor in adults. Some of the genetic variations identified thus far, such as mutation and promotor methylation, have implications for...
8.
Kapur R, Bellizzi A, Bond S, Chen H, Han J, LeGallo R, et al.
Am J Surg Pathol
. 2021 Jan;
45(8):1047-1060.
PMID: 33492848
Congenital myenteric hypoganglionosis is a rare developmental disorder characterized clinically by severe and persistent neonatal intestinal pseudoobstruction. The diagnosis is established by the prevalence of small myenteric ganglia composed of...
9.
Velazquez Vega J, Brat D, Ryken T, Olson J
J Neurooncol
. 2020 Nov;
150(2):143-164.
PMID: 33215342
Target Population: These recommendations apply to adult patients with newly diagnosed or suspected glioblastoma (GBM) QUESTION : For adult patients with newly diagnosed GBM does testing for Isocitrate Dehydrogenase 1...
10.
Goodman A, Velazquez Vega J, Rey Martinez L, Brat D, Schniederjan M
J Neuropathol Exp Neurol
. 2020 Sep;
79(12):1376-1378.
PMID: 32935128
No abstract available.